Assignment: Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

For this Assignment, you will complete a focused SOAP note for a patient in a case study who has either a schizophrenia spectrum, other psychotic, or medication-induced movement disorder.

To Prepare

• Review this       week’s Learning Resources. Consider the insights they provide about       assessing, diagnosing, and treating schizophrenia spectrum, other       psychotic, and medication-induced movement disorders.
• Review the      Focused SOAP Note template, which you will use to complete this      Assignment. There is also a Focused SOAP Note Exemplar provided as a guide      for Assignment expectations.
• Review the      video, Case Study: Sherman Tremaine. You will use this case as      the basis of this Assignment. In this video, a Walden faculty member is      assessing a mock patient. The patient will be represented onscreen as an      avatar.
• Consider what      history would be necessary to collect from this patient.
• Consider what      interview questions you would need to ask this patient.

The Assignment

Develop a focused SOAP note, including your differential diagnosis and critical-thinking process to formulate a primary diagnosis. Incorporate the following into your responses in the template:

• Subjective: What details      did the patient provide regarding their chief complaint and symptomology      to derive your differential diagnosis? What is the duration and severity      of their symptoms? How are their symptoms impacting their functioning in      life?
• Objective: What      observations did you make during the psychiatric assessment?
• Assessment: Discuss      the patient’s mental status examination results. What were your      differential diagnoses? Provide a minimum of three possible diagnoses with      supporting evidence, and list them in order from highest priority to      lowest priority. Compare the DSM-5-TR diagnostic criteria      for each differential diagnosis and explain what DSM-5-TR criteria      rules out the differential diagnosis to find an accurate diagnosis.      Explain the critical-thinking process that led you to the primary      diagnosis you selected. Include pertinent positives and pertinent      negatives for the specific patient case.
• Plan: What is      your plan for psychotherapy? What is your plan for treatment and      management, including alternative therapies? Include pharmacologic and      nonpharmacologic treatments, alternative therapies, and follow-up      parameters, as well as a rationale for this treatment and management      plan. Also incorporate one health promotion activity and one patient      education strategy.
• Reflection      notes: What      would you do differently with this patient if you could conduct the      session again? Discuss what your next intervention would be if you      were able to follow up with this patient. Also include in your reflection      a discussion related to legal/ethical considerations (demonstrate critical      thinking beyond confidentiality and consent for treatment!), health      promotion, and disease prevention, taking into consideration patient factors      (such as age, ethnic group, etc.), PMH, and other risk factors (e.g.,      socioeconomic, cultural background, etc.).
• Provide at      least three evidence-based, peer-reviewed journal articles or      evidenced-based guidelines that relate to this case to support your      diagnostics and differential diagnoses. Be sure they are current (no more      than 5 years old).

Medication Review

Review the FDA-approved use of the following medicines related to treating schizophrenia-spectrum and other psychotic disorders:

 

Psychosis

Schizoaffective    disorder

 

alprazolam (adjunct)
amisulpride
aripiprazole
asenapine
blonanserin
carbamazepine (adjunct)
chlorpromazine
clonazepam (adjunct)
clozapine
cyamemazine
flupenthixol
fluphenazine
haloperidol
iloperidone
lamotrigine (adjunct)
lorazepam (adjunct)
loxapine
lurasidone

mesoridazine
molindone
olanzapine
paliperidone
perospirone
perphenazine
pimozide
pipothiazine
quetiapine
risperidone
sertindole
sulpiride
thioridazine
thiothixene
trifluoperazine
valproate (divalproex) (adjunct)
ziprasidone
zotepine
zuclopenthixol

amisulpride
aripiprazole
asenapine
carbamazepine (adjunct)
chlorpromazine
clozapine
cyamemazine
flupenthixol
haloperidol
iloperidone
lamotrigine (adjunct)
l-methylfolate (adjunct)
loxapine
lurasidone
mesoridazine
molindone
olanzapine
paliperidone

perospirone
perphenazine
pipothiazine
quetiapine
risperidone
sertindole
sulpiride
thioridazine
thiothixene
trifluoperazine
valproate (divalproex) (adjunct)
ziprasidone
zotepine
zuclopenthixol

 

Schizophrenia

Cataplexy syndrome

Catatonia

Extrapyramidal side    effects

 

amisulpride
aripiprazole
asenapine
carbamazepine (adjunct)
chlorpromazine
clozapine
cyamemazine
flupenthixol
haloperidol
iloperidone
lamotrigine (adjunct)
l-methylfolate (adjunct)
loxapine
lurasidone
mesoridazine
molindone
olanzapine
paliperidone
perospirone

perphenazine
pipothiazine
quetiapine
risperidone
sertindole
sulpiride
thioridazine
thiothixene
trifluoperazine
valproate (divalproex) (adjunct)
ziprasidone
zotepine
zuclopenthixol
Seasonal affective disorder
bupropion
Sedation-induction
hydroxyzine
midazolam

clomipramine
imipramine
sodiu

 

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer. (For review as needed)

• Chapter 7, “Schizophrenia      Spectrum and Other Psychotic Disorders”
• Chapter 29.2,      “Medication-Induced Movement Disorders”
• Chapter 29.3, “α2-Adrenergic      Receptor Agonists, α1-Adrenergic Receptor Antagonists:      Clonidine, Guanfacine, Prazosin, and Yohimbine”

Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (Eds.). (2015). Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell.

· Chapter 43, “Pharmacological, Medically-Led and Related Disorders”

· Chapter 57, “Schizophrenia and Psychosis”

Zakhari, R. (2021). The psychiatric-mental health nurse practitioner certification review manual. Springer Publishing Company.

· Chapter 9, “Psychotic Disorders and Delusions”

REQUIRED MEDIA